MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.
Hospital for Special Surgery, New York, New York, United States
Georgia Knee and Sports Medicine, Decatur, Georgia, United States
Boulder Neurological Associates, Boulder, Colorado, United States
Chattanooga Center for Neurological Research, Chattanooga, Tennessee, United States
VA Loma Linda Healthcare System, Loma Linda, California, United States
Limb Preservation Platform, Inc., Fresno, California, United States
Center for Clinical Research, Inc., Eugene, Oregon, United States
Professional Education and Research Institute, Roanoke, Virginia, United States
Dermatology Cosmetic Laser Medical Associates of LaJolla, Inc., San Diego, California, United States
St. Johns Outpatient Wound Center, Tulsa, Oklahoma, United States
Professional Education and Research Institute, Inc., Roanoke, Virginia, United States
Beacon Orthopaedics & Sports Medicine, Sharonville, Ohio, United States
Jackson South Urology Center of Excellence, Miami, Florida, United States
Center for Clinical Research Inc, Castro Valley, California, United States
Novak Urgent Care and Family Practice, Indio, California, United States
Palmtree Clinical Research, Inc., Palm Springs, California, United States